Travere Therapeutics (TVTX) Announces Data Presentations of

Travere Therapeutics (TVTX) Announces Data Presentations of Interim Analysis from Phase 3 PROTECT Study of FILSPARI

Travere Therapeutics (TVTX) Announces Data Presentations of Interim Analysis from Phase 3 PROTECT Study of FILSPARI
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan , Thailand , United States , Bangkok , Krung Thep Mahanakhon , Naomi Eichenbaumvice , Nivi Nehravice , Travere Therapeutics Inc , Exchange Commission , Corporate Communications , Nasdaq , World Congress , European Union , Company Annual Report On Form , Bits Association , Wall Street , Clinical Meetings , Dual Endothelin Angiotensin Receptor Antagonist , Reduces Proteinuria , Interim Results , Late Breaking Clinical Trialsoral Presentation , Plenary Hall , Patient Baseline Characteristics , Asian Regions , Young Patients , Label Extensionposter , Sustained Proteinuria Reduction , Interim Resultslate Breaking , Sparsentan Treatment , Label Extension , Disease Progression , Iga Nephropathy , Important Safety , Some Endothelin Receptor Antagonists , Upper Limit , Fetal Toxicity , Kidney Injury , Angiotensin System , Acid Reducing Agents , Steroidal Anti Inflammatory Agents , Including Selective , Increasing Serum Potassium , Reproductive Potential , Full Prescribing Information , Travere Therapeutics , Private Securities Litigation Reform Act , Annual Report , Nivi Nehravice President , Naomi Eichenbaumvice President , Investor Relations ,